In colorectal cancer, miR-148a-3p is eminently capable of repressing the expression of calnexin (CANX) and B2M/MHC-I, thereby decidedly restricting the anti-cancer efficacy of CTLs (48). The gene discussed is B2M; the disease is colorectal cancer.